Kramer Michael S, Matush Lidia, Vanilovich Irina, Platt Robert W, Bogdanovich Natalia, Sevkovskaya Zinaida, Dzikovich Irina, Shishko Gyorgy, Collet Jean-Paul, Martin Richard M, Davey Smith George, Gillman Matthew W, Chalmers Beverley, Hodnett Ellen, Shapiro Stanley
Department of Pediatrics, McGill University Faculty of Medicine, Montreal, PQ, Canada.
Am J Clin Nutr. 2007 Dec;86(6):1717-21. doi: 10.1093/ajcn/86.5.1717.
The evidence that breastfeeding protects against obesity and a variety of chronic diseases comes almost entirely from observational studies, which have a potential for bias due to confounding, selection bias, and selective publication.
We assessed whether an intervention designed to promote exclusive and prolonged breastfeeding affects children's height, weight, adiposity, and blood pressure at age 6.5 y.
The Promotion of Breastfeeding Intervention Trial (PROBIT) is a cluster-randomized trial of a breastfeeding promotion intervention based on the WHO/UNICEF Baby-Friendly Hospital Initiative. A total of 17,046 healthy breastfed infants were enrolled from 31 Belarussian maternity hospitals and their affiliated clinics; of those infants, 13,889 (81.5%) were followed up at 6.5 y with duplicate measurements of anthropometric variables and blood pressure. Analysis was based on intention to treat, with statistical adjustment for clustering within hospitals or clinics to permit inferences at the individual level.
The experimental intervention led to a much greater prevalence of exclusive breastfeeding at 3 mo in the experimental than in the control group (43.3% and 6.4%, respectively; P < 0.001) and a higher prevalence of any breastfeeding throughout infancy. No significant intervention effects were observed on height, body mass index, waist or hip circumference, triceps or subscapular skinfold thickness, or systolic or diastolic blood pressure.
The breastfeeding promotion intervention resulted in substantial increases in the duration and exclusivity of breastfeeding, yet it did not reduce the measures of adiposity, increase stature, or reduce blood pressure at age 6.5 y in the experimental group. Previously reported beneficial effects on these outcomes may be the result of uncontrolled confounding and selection bias.
母乳喂养可预防肥胖和多种慢性疾病的证据几乎完全来自观察性研究,这类研究因存在混杂因素、选择偏倚和选择性发表而可能产生偏倚。
我们评估了一项旨在促进纯母乳喂养和延长母乳喂养时间的干预措施对6.5岁儿童身高、体重、肥胖程度和血压的影响。
母乳喂养促进干预试验(PROBIT)是一项基于世界卫生组织/联合国儿童基金会爱婴医院倡议的母乳喂养促进干预措施的整群随机试验。从白俄罗斯的31家妇产医院及其附属诊所招募了总共17046名健康的母乳喂养婴儿;其中13889名(81.5%)婴儿在6.5岁时接受了随访,对人体测量变量和血压进行了重复测量。分析基于意向性治疗原则,对医院或诊所内的聚类进行了统计调整,以便在个体层面进行推断。
与对照组相比,实验性干预使实验组3个月时纯母乳喂养的患病率显著更高(分别为43.3%和6.4%;P<0.001),并且在整个婴儿期任何形式母乳喂养的患病率也更高。未观察到对身高、体重指数、腰围或臀围、肱三头肌或肩胛下皮褶厚度、收缩压或舒张压有显著的干预效果。
母乳喂养促进干预措施使母乳喂养的持续时间和纯母乳喂养率大幅提高,但在实验组中,该措施并未降低6.5岁时的肥胖指标、增加身高或降低血压。先前报道的对这些结果的有益影响可能是未控制的混杂因素和选择偏倚导致的。